Fig. 1
Distribution of tumor size among four groups of patients using A, bi-dimensional (2D) measurement and B, volumetric (3D) measurement. One outlier measurement in the CCNU 2001-2004 was excluded from the graph of the 3D measurement group to prevent compression of the graph scale. In both 2D and 3D measurement analyses, the average tumor sizes of the CCNU 2009-2015 group were below the average tumor sizes of the entire cohort. CCNU indicates lomustine; 3D, 3-dimensional.

Distribution of tumor size among four groups of patients using A, bi-dimensional (2D) measurement and B, volumetric (3D) measurement. One outlier measurement in the CCNU 2001-2004 was excluded from the graph of the 3D measurement group to prevent compression of the graph scale. In both 2D and 3D measurement analyses, the average tumor sizes of the CCNU 2009-2015 group were below the average tumor sizes of the entire cohort. CCNU indicates lomustine; 3D, 3-dimensional.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close